Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
We had to run our own trial for TB drugs – nobody else was doing it

Four years ago, Médecins Sans Frontières (MSF) made the decision to sponsor and run its own tuberculosis clinical trial. The aim was to find a new treatment regimen for drug-resistant tuberculosis (TB) that was radically better than what was currently available. As an organisation that specialises in delivering short-term emergency healthcare, this was a bold and new direction to take. But it was a decision that came from our frustration, anger and impatience on behalf of the more than 20,000 people with TB that we treat every year. We felt compelled to search for improved treatments ourselves because too few pharmaceutical companies, organisations or universities were doing enough about it.

Published
02 June 2017
From
The Guardian
MDR-TB numbers could keep growing despite improved treatment

Up to one-in-three tuberculosis cases in Russia could be multidrug resistant by 2040, and one-in-eight in India, unless more is done to stop the person-to-person

Published
11 May 2017
By
Keith Alcorn
TB/HIV outreach finding patients in remote South Africa

A novel tuberculosis and HIV case-finding method effectively detected people with both diseases in a remote area of South Africa, according to researchers.

Published
10 May 2017
From
Healio
Multidrug-resistant tuberculosis in migrants, multi-country cluster

A multi-country cluster of multidrug-resistant tuberculosis (MDR TB) involving 28 migrants has been delineated by whole genome sequencing (WGS) in migrants recently having arrived from countries in the Horn of Africa. Although the number of cases detected so far is small, there is a possibility that more cases associated with this cluster may still be identified.

Published
14 April 2017
From
ECDC
Health system navigators didn't improve ART initiation or TB treatment completion rates among people newly diagnosed with HIV in Durban

An intervention using health system navigators, phone support and text message reminders did not improve rates of people living with HIV initiating antiretroviral therapy (ART) or completing treatment

Published
10 April 2017
By
Michael Carter
South Africa: 'We Can't Accept the New HIV, TB Plan' - Treatment Action Campaign

The new national strategic plan for HIV and TB is a plan that seems reasonable when considered in the abstract, but that risks falling apart when confronted by the realities of the public healthcare system and political context.

Published
04 April 2017
From
AllAfrica
South Africa launches new plan to advance progress towards ending AIDS

In the plan are a set of bold and ambitious targets which include reducing new HIV infections from 270 000 to less than 100 000 per year, reducing new tuberculosis (TB) infections from 450 000 to less than 315 000 per year and reaching the 90–90–90 targets.

Published
04 April 2017
From
UNAIDS
Ensuring Migrants Have Access To HIV, TB Treatment Critical To Reversing Epidemics In Eastern Europe, Central Asia

Michel Kazatchkine: There must be a halt to the deportation of migrants based on health status in the countries where it is still in practice; the region needs to ensure migrants have access to HIV services, including ART, and to full course TB/MDR-TB treatment in the host country; national and regional responses around infectious diseases like HIV and TB urgently need to be reviewed to include migrants as a vulnerable group.

Published
27 March 2017
From
Kaiser Daily Global Health Policy Report / Huffington Post
UNAIDS warns that countries will miss the 2020 target of reducing HIV-associated TB deaths by 75% unless urgent action is taken

On World Tuberculosis Day, 24 March, UNAIDS is urging countries to do much more to reduce the number of tuberculosis (TB) deaths among people living with HIV. TB is the most common cause of hospital admission and death among people living with HIV. In 2015, 1.1 million people died from an AIDS-related illness—around 400 000 of whom died from TB, including 40 000 children.

Published
27 March 2017
From
UNAIDS press release
Tuberculosis: Fewer than five per cent of people in need are treated with new drugs

Outside of a small number of clinical trials and compassionate use programmes, only 469 people received delamanid in 2016, while just over 4,300 received bedaquiline. All other people receiving DR-TB treatment continue instead to be treated with older, more toxic regimens that cure only 50 per cent of people treated, and cause severe side-effects, ranging from deafness to psychosis.

Published
27 March 2017
From
Médecins Sans Frontières (MSF) International
← First12345...104Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.